Cargando…
Lipocalin 2 negatively regulates cell proliferation and epithelial to mesenchymal transition through changing metabolic gene expression in colorectal cancer
Lipocalin 2 (LCN2), a member of the lipocalin superfamily, plays an important role in oncogenesis and progression in various types of cancer. However, the expression pattern and functional role of LCN2 in colorectal cancer (CRC) is still poorly understood. The purpose of the present study was to inv...
Autores principales: | Kim, Se‐Lim, Lee, Soo Teik, Min, In Suk, Park, Young Ran, Lee, Ju Hyung, Kim, Dae‐Ghon, Kim, Sang‐Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666039/ https://www.ncbi.nlm.nih.gov/pubmed/28859238 http://dx.doi.org/10.1111/cas.13389 |
Ejemplares similares
-
Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK-mediated DR5 regulation in colorectal cancer
por: Kim, Se-Lim, et al.
Publicado: (2019) -
Parthenolide inhibits transforming growth factor β1-induced epithelial-mesenchymal transition in colorectal cancer cells
por: Zhu, Shi Mao, et al.
Publicado: (2019) -
Aptamer-based Sandwich Assay and its Clinical Outlooks for Detecting Lipocalin-2 in Hepatocellular Carcinoma (HCC)
por: Lee, Kyeong-Ah, et al.
Publicado: (2015) -
Lipocalin-2 negatively regulates epithelial–mesenchymal transition through matrix metalloprotease-2 downregulation in gastric cancer
por: Nishimura, Sadaaki, et al.
Publicado: (2022) -
Role of LOXL2 in the epithelial-mesenchymal transition and colorectal cancer metastasis
por: Park, Pil-Gu, et al.
Publicado: (2017)